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Gender differences in response to an opportunistic brief intervention for obesity in 
primary care: Data from the BWeL trial  
 
Summary 
Weight loss programmes appeal mainly to women, prompting calls for gender-specific 
programmes. In the UK, GPs refer nine times as many women as men to community weight 
loss programmes. GPs endorsement and offering programmes systematically could reduce 
this imbalance. In this trial, consecutively attending patients in primary care with obesity 
were invited and 1882 were enrolled and randomized to one of two opportunistic 30-second 
interventions to support weight loss given by GPs in consultations unrelated to weight. In the 
support arm, clinicians endorsed and offered referral to a weight loss programme and, in the 
advice arm, advised that weight loss would improve health. Generalized linear mixed effects 
models examined whether gender moderated the intervention. Men took effective weight loss 
action less often in both arms (Support: 41.6% versus 60.7%; Advice: 12.1% versus 18.3%; 
OR=0.38, 95%CI, 0.27, 0.52, p<0.001) but there was no evidence that the relative effect 
differed by gender (interaction p=0.32). In the support arm, men accepted referral and 
attended referral less often, 69.3% versus 82.4%; OR=0.48, 95%CI, 0.35, 0.66, p<0.001 and 
30.4% versus 47.6%; OR=0.48, 95%CI, 0.36, 0.63, p<0.001 respectively. Nevertheless, the 
gender balance in attending weight loss programmes closed to 1.6:1. Men and women 
attended the same number of sessions (9.7 vs 9.1 sessions, p=0.16) and there was no evidence 
weight loss differed by gender (6.05kg men versus 4.37kg women, p=0.39). Clinician-
delivered opportunistic 30-second interventions benefits men and women equally and reduce 





What is already known 
 Structured community weight loss programmes are more effective in achieving weight 
loss than unguided weight loss attempts. 
 Such programmes are used overwhelming by women, with one in 20 users being men. 
Even when referred by GPs, 1 in 10 are men. Community weight loss programmes 
present themselves as highly feminised. 
 Men express preferences for weight loss support that runs differently and it is assumed 
that men’s behaviour and preferences are immutable and that weight loss programmes 
tailored to men are required. 
  
What this study adds 
 In this trial, GPs opportunistically offered weight loss support, including referral to 
community weight loss programmes to unselected patients with obesity attending for 
routine medical care. 
 Seven in 10 men accepted a referral and were nearly as likely as women to do so. Three 
in 10 men compared with 5 in 10 women attended the programme. This uptake closed 
the gender gap in referrals from 9:1 to 1.6:1. 
 When GPs endorse and offer referral, this removes most of the gender gap in uptake of 





The prevalence of obesity  in men and women is similar [1] as is the proportion of men and 
women with obesity who are trying to lose weight [2]. However, findings from high income 
countries indicate that men are less likely to attend weight loss programmes [3-5]. For 
example, in an audit of 1.3 m people attending a weight loss programme in the UK, only 5% 
of users were men [3]. This matters because self-directed weight loss attempts are less 
successful than supported attempts [6]. Men are also less likely to receive treatment for 
obesity in routine clinical practice [7 8] and are underrepresented in clinical trials of weight 
loss interventions [5 9 10]. 
 
This gender gap has attracted considerable attention. In 2014, a series of systematic reviews 
examined the effect of gender on the clinical effectiveness and cost-effectiveness of 
interventions to treat obesity [5]. These found that men expressed a preference for fact-based 
advice, delivered in social settings and programmes with a greater emphasis on physical 
activity. This has led to efforts to develop programmes with specific appeal to men, notably 
the Football Fans in Training (FFIT) scheme. Here a 12-week programme was developed for 
men and delivered in football/soccer clubs which led to a mean weight loss of 5.6 kg at one 
year compared with 0.6 kg weight loss among participants in a waiting list control group 
[11]. However, the reviews also showed that men who attended mixed gender programmes 
were successful in losing weight. Indeed, once enrolled, men were less likely than women to 
drop out of programmes than women and lost relatively more weight [5]. Surprisingly, there 
has been little attention given to attracting more men to existing mixed gender community 
weight loss group programmes that are already known to be effective [12-15]. This approach 
is likely to be less costly and quicker to implement than developing, evaluating and scaling 
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up novel gender-specific schemes since it could use the established population scale 
infrastructure for weight management.  
 
In routine clinical practice in the UK, only 10% of primary care referrals to community 
weight loss programmes are for men [4 16]. However, this in itself does not show whether 
clinicians do not offer referrals to men or whether men decline it. In the current pre-planned 
exploratory study, we examine how men react to an opportunistic face-to-face brief 
intervention by a primary care clinician compared with women and whether this closes the 




Study design and participants 
The trial was approved by the NHS Research Ethics Service and registered prospectively 
ISRCTN: 26563137. The protocol and the primary outcome have been published previously 
[17 18]. The study was a parallel, two-arm randomized trial of a brief intervention for the 
treatment of obesity. Researchers screened consecutively attending patients at general 
practices in England. Patients who were identified as having obesity using ethnic specific cut-
offs were invited to participate [19]. If they agreed they were screened for eligibility. People 
with limited English, people who were already attending or had attended a structured weight 
loss programme in the last three months, or women who were or were intending to become 
pregnant were excluded.  
 
At the end of the consultation clinicians randomly delivered one of two opportunistic brief 
interventions to all eligible participants. In the ‘support’ arm, clinicians endorsed, offered, 
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and facilitated a referral to one of two commercially-delivered 12-week weight loss 
programmes, which were offered free of charge, as in the English NHS. The number of 
people who accepted the referral was recorded and they were given an appointment before 
leaving the practice. Both programmes are well known in the UK and are advertised in the 
community, mainly to women who represent 95% of attendees [3]. In the ‘advice’ (control) 
arm, clinicians advised participants to lose weight to benefit their health but did not offer 
referral to a weight loss program. Both the support and advice interventions were designed to 
be delivered in 30 seconds. The trial showed that when clinicians opportunistically endorse, 
offer, and facilitate a referral of unselected patients with obesity to a community weight loss 
program, this was well received and led to greater weight loss at one year than when 
clinicians advised weight loss alone [17 18]. 
 
At three and 12 months we assessed the actions that people had taken to lose weight. We 
defined taking ‘some action’ as any self-directed effort to control diet or increase activity. We 
defined taking ‘effective action’ as following a total or partial meal-replacement weight loss 
program, taking orlistat, or attending a weight loss programme at either three or 12 months 
since there is evidence that each of these approaches is more effective than self-directed 
action [6]. We assessed the number of attendances using data from Slimming World, the 
weight loss programme chosen by 94% of participants who accepted a referral in the support 
arm. Weight was measured in light clothing at baseline and 12 months. 
 
Outcomes and statistical analyses 
For all analyses we used generalized linear mixed effects models. The link function was 
either a logistic term for binary outcomes or identity function for continuous outcomes. 
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Participant randomization was stratified by general practice, so this was added as a random 
effect for all analyses.  Analyses were conducted in SPSS version 23.  
 
Did trial enrolment differ by gender? 
Of those invited to participate, we examined whether men were more or less likely to be 
enrolled. The outcome variable was trial enrolment and the denominator was all those 
screened with an eligible body mass index (BMI) and body fat percentage. We examined 
whether any differences between genders could be explained by the prevalence of exclusion 
criteria (e.g. pregnancy, recently or currently attending a weight loss program).   
 
Did gender moderate the effect of the intervention on weight loss attempts, use of effective 
aids to weight loss, or weight loss? 
We examined whether gender moderated the effectiveness of the intervention in promoting 
action to lose weight. The model to do so included baseline weight, trial arm, and the 
interaction between gender and trial arm. The denominator was all enrolled participants. For 
the first analysis, the outcome variable was any reported action to lose weight (i.e. self-
directed efforts or effective action). For the second analysis, the outcome variable was people 
specifically reporting taking effective action to manage their weight. 
 
We also examined whether the effect of trial arm on weight loss differed by gender; including 
baseline weight, trial arm, gender, and the interaction between gender and trial arm. The 
outcome variable was weight at 12 months. We weighed 1419 (75%) participants at 12 
months. Otherwise, we imputed missing weights at 12 months using the baseline observation 




Did men and women differ in the response to clinicians’ brief interventions? 
In the support arm only, we examined whether gender was associated with accepting the 
clinician’s referral to a weight loss programme (i.e. telling the clinician that they would 
attend). The denominator was everybody in the support arm. We also examined whether men 
differed from women in the likelihood of attending the programme at least once, which 
amounts to acting on the clinician’s recommendation. We assessed attendance among all 
those randomized to the support arm and among those who accepted the referral. To examine 
whether the programme was acceptable to those who experienced it at least once, we 
examined whether mean number of attendances at the programme differed by gender, with 
the denominator being all those who attended at least once.   
 
Results 
Did trial enrolment differ by gender? 
Between June 4, 2013 and Dec 23, 2014, 2730 people with obesity were offered enrolment in 
the trial. Of these, 1637 were women and 1064 were men. Data for gender was missing for 29 
potentially eligible patients and these people were excluded from further analyses. A greater 
proportion of men who were potentially eligible were enrolled compared with women (75.8 
vs 65.7%, odds ratio (OR)=1.63, 95% confidence interval (CI), 1.36, 1.95, p<0.001). This 
was because a smaller proportion of men were not eligible to participate compared with 
women (3.9 vs 13.3%, OR=0.35, 95%CI, 0.26, 0.48, p<0.001), primarily because men were 
less likely to be currently or recently participating in a weight loss program, although 
pregnancy or intended pregnancy also excluded some women (Table 1).  Clinicians deemed it 
inappropriate to make an opportunistic brief intervention to the same proportion of men and 
women (4.5%, OR= 1.00, 95%CI, 0.71, 1.39, p=0.99). There was no evidence of gender 
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differences in the proportion of people who declined to participate (16 vs 17%, OR= 0.93, 
95%CI 0.75, 1.15, p=0.50). 
 
Did gender moderate the effect of the intervention on weight loss attempts, use of 
effective aids to weight loss, or weight loss? 
Data on actions to lose weight were available for 1560 participants (657 men and 903 
women) (Table 2).  The clinician’s offer of support increased the proportion of people taking 
action to manage their weight from 83.0% in the advice arm to 88.9% OR = 1.62, 95%CI, 
1.21, 2.16, p=0.001 but there was no evidence overall that the proportion of men and women 
taking action differed (OR=0.75, 95%CI, 0.47, 1.20, p=0.23). There was also no evidence 
that men and women differed in their response to the support intervention; 87.7% of men and 
89.6% of women in the support arm took action compared with 83.0% of men and 83.1% of 
women in the advice arm (p=0.60 for the interaction).  
 
Altogether, 52.8% of participants in the support arm took effective action to manage their 
weight compared with 15.6% in the advice arm (OR = 6.12, 95%CI, 4.82, 7.78, p<0.001). 
For the main effects of the model,  men were less likely than women to take effective action 
in both support and advice arms, with 41.6% of men and 60.7% of women taking effective 
action in the support arm and 12.1% of men and 18.3% of women in the advice arm doing so 
(OR = 0.38, 95%CI, 0.27, 0.52, p<0.001). There was no evidence that the relative effect of 
the support arm differed by gender (p=0.32 for the interaction). 
 
At 12 months we collected weight data for 1419 participants (73% of men and 77% of 
women) and weight loss was 2.43kg (6.49) in the support arm and 1.04kg (5.50) in the advice 
arm. In the support arm, weight loss in men was 2.39kg (6.71) compared with 2.46kg (6.32) 
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in women. In the advice arm, weight loss in men was 0.68kg (5.71) compared with 1.32kg 
(5.33) in women. There was no evidence that gender moderated the relationship between 
intervention group and weight loss (p=0.26 for the interaction).  
 
Did men and women differ in the response to clinicians’ brief interventions? 
There were 401 men and 539 women assigned to the support arm and were offered a referral 
to a weight loss program. Men were less likely than women to accept the referral (69.3 vs 
82.4%; OR=0.48, 95%CI, 0.35, 0.66, p<0.001) (Table 3).  
 
Among all those in the support arm, 379 (40.3%) people attended a weight loss program, but 
men were less likely to do so than women (30.4 vs 47.6%; OR=0.48, 95%CI, 0.36, 0.63, 
p<0.001). In those accepting a referral, men were less likely to attend the programme (43.2 vs 
57.9%; OR=0.58, 95%CI, 0.43, 0.79, p<0.001). Of those who attended the programme at 
least once, there was no evidence of a difference by gender in the number of sessions 
attended (9.7 vs 9.1; mean difference=0.62, 95%CI, -0.25, 1.48, p=0.16). Among this group, 
men lost slightly but not significantly more weight than women at 12 months; 6.05kg (8.56) 
compared with 4.37kg (7.57), mean adjusted difference=0.80, 95%CI, -1.01, 2.62 (p=0.39) 





More than four in five men and women opportunistically approached in a primary care clinic 
volunteered to enrol in a trial of brief interventions for obesity. Randomization to a clinician 
offering, endorsing, and facilitating a referral to a weight loss programme increased the 
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proportion of men and women taking action to lose weight. There was no evidence of a 
gender difference in the effect of the intervention itself, but overall, men were less likely to 
take effective action to manage their weight than women. This was manifest in a greater 
proportion of men declining the clinician’s offer of a referral and, among those who agreed to 
it, a smaller proportion of men attending the programme compared with women.  However, 
once enrolled in the program, men attended a similar number of sessions as women and there 
was no evidence that weight loss at 12 months differed by gender. 
 
Strengths and limitations 
This is the first analysis of the effect of an intervention that can be delivered by clinicians in 
routine practice to increase the engagement of men to established mixed gender weight loss 
programmes.  It is based on a randomized controlled trial in which 75% of participants were 
weighed, which is higher than the typical follow up in similar weight loss trials (63%) [20].   
 
While we planned these exploratory analyses [17] these subgroup analyses did not inform the 
sample size calculations. In many cases, we did not detect differences between men and 
women, but the trial was not planned to have sufficient power to detect these subgroup 
effects and the precision of the confidence intervals means that we may have missed modest 
but important differences in effectiveness by gender. We cannot therefore conclude that the 
intervention effect does not differ by gender, only that there is no evidence that it does so and 
that there are no moderate or large differences.  
 
Comparison with existing literature 
Five percent of paying customers of the commercial weight loss group programmes are men 
[3], while 10% of people referred by clinicians to these programmes are men [4 16].  Why 
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might men be so under-represented in such programmes? Previous findings have suggested 
that men view community weight loss programmes as feminized spaces [21 22]. The 
evidence here is that such a perception can be easily overcome by clinicians endorsing and 
offering referral. We asked participants to rate the acceptability of the referral to a weight 
loss programme immediately after the consultation, and there was no evidence that scores 
differed between men and women. Moreover, men’s behaviour in this trial shows clear 
evidence of the broad acceptability of these programmes to most men. Here 39% of 
participants in the weight loss programme were men and the gender ratio in attendance was 
1:1.6 compared with 1:10 in routine primary care. This is reinforced by data from two clinical 
trials where men and women were offered an equal opportunity to attend a weight loss 
programme by receiving an invitation letter to do so [10 13]. Around a third of people 
enrolled were men, a gender ratio of 1:1.9 in a trial where the gender mix of the invited 
population was known. As Figure 1 suggests, most of the gender imbalance in paying 
customers appears to be due to men’s reluctance to enrol in such programmes. However, this 
trial suggests that the gender imbalance in routine primary care is because clinicians offer 
programmes mainly to women, perhaps because they perceive such programmes to be 
gendered. Data from this trial shows, however, that three quarters of the large gender 
imbalance is removed by clinicians spending 30 seconds to endorse and offer such a program.  
 
Our findings also indicate that when men attended at least one session of the program, they 
remained as engaged as women (attending the same number of total sessions) and lost a 
similar amount of weight. This is consistent with evidence from a clinical trial [15] and an 
audit of people who chose to self-fund attendance at similar programmes [3].  Once men are 





Many national guidelines recommend that clinicians refer men and women with obesity to 
behavioural weight loss programmes [23-25]. However, the frequency of brief interventions 
and attendance at programmes is much lower than occurred in this trial [26 27], suggesting 
that clinicians are not adhering to guidelines. There is evidence that clinicians do not offer 
referrals to weight loss programmes opportunistically because  they are concerned about the 
best way to initiate conversations about weight loss [28 29]. Where conversations do occur, 
these are usually initiated by patients not clinicians [26].  Since men are less likely to 
problematize their weight than women [22], they may raise the issue with their clinician less 
often, reducing the likelihood of being offered support. These results should reinforce 
clinicians’ sense of capability at having these conversations. A relatively brief intervention 
with a clinician was able to overcome a preference against apparently feminine weight loss 
programmes that many had regarded as immutable. 
 
Implications for research and practice 
Currently, clinician referrals represent a small proportion of all people using community 
weight loss programmes; most users are self-payers, and nearly all of them are women. 
Research is needed to understand how else we can counter the perception that these 
programmes are designed for and best suited to women. If a 30-second intervention by a 
clinician can remove three quarters of the gender imbalance, this should encourage efforts to 
do so for self-payers, because this perception seems easily malleable. 
 
These results have direct application to clinical practice. It appears that clinicians mainly 
offer to refer women to weight loss programmes, perhaps because they share the widespread 
belief that these are feminized and unsuitable for men. However, clinicians can be reassured 
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that their endorsement appears to counter that and three quarters of the gender imbalance in 
referrals can be removed by clinicians endorsing and offering such programmes equally to 
men and women. Men and women benefited markedly and equally from these brief 
opportunistic interventions. 
 
Currently there is no direct evidence that gender-specific interventions, for example those 
delivered in sports clubs or at work, are more effective or cost-effective for men than existing 
evidence-based programmes. The FFIT program, specifically developed and tested for men 
resulted in a mean weight loss of 5.6 kg at one year with an intervention lasting 12 sessions 
and costing an estimated £680 [11]. A trial of a mixed gender community weight loss group 
for 12 or 52 weeks shows mean weight losses at 1 year of 4.8 and 6.8kg costing £60 or £195 
respectively (15). While gender-specific programmes may be useful for men who are 
unwilling to attend existing services, such programmes are not yet widely available. Policy 
might therefore focus more on implementing brief interventions as a way to reach men rather 
than on developing bespoke weight loss programmes for them.  
 
Conclusions 
Brief opportunistic interventions by clinicians to unselected patients with obesity to endorse, 
offer, and facilitate a referral to an effective weight loss programme slightly increase the 
proportion of men and women taking action on their weight and markedly increase the 
proportion taking effective action. Brief opportunistic interventions work equally effectively 
in men and women and remove three quarters of the gender imbalance in referrals to these 
programmes seen in routine care. Once enrolled, men attend and achieve as much weight loss 
as women do. Clinicians can use these findings to more frequently offer referrals to these 
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Table 1 Proportion of potentially eligible patients enrolling in the trial by gender  











Eligible BMI/invited  1064  1637  29     
Declined participation (%)  167 (15.7)  271 (16.6)  18  0.93 (0.75, 1.15)  0.50 
Not eligible for other reasons (%)*  41 (3.9)  218 (13.3)  3  0.35 (0.26, 0.48)  <0.001 
  Pregnant   0 (0)  34 (2.1)  0    ‐ 
  Participating in weight loss program  14 (<1)  58 (3.5)  1    ‐ 
  Participated in weight loss programme in       
past 3 months 
13 (1.2)  64 (3.9)  1    ‐ 
  Visiting clinician for weight‐loss  5 (<1)  21 (1.3)  0    ‐ 
  Poor English language skills  3 (<1)  5 (<1)  0    ‐ 
Clinician deemed brief intervention 
participation inappropriate (%) 
48 (4.5)  74 (4.5)  0  1.00 (0.71, 1.39)  0.99 
Enrolled (%)  806 (75.8)  1076 (65.7)  0  1.63 (1.36, 1.95)  <0.001 
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Effective action   41 (12.1)  84 (18.3)  125 (15.6)  132 (41.6)  269(60.7)  401 (52.8) 
Some action    241 (70.9)  298 (64.8)  539 (67.4)  146 (46.1)  128 (28.9)  274 (36.1) 
No action   58 (17.1)  78 (17.0)  136 (17.0)  39 (12.3)  46 (10.4)  85 (11.2%) 
12‐m weight loss 
(BOCF) (kg)  
0.68 (5.71)  1.32 (5.33)  1.04 (5.50)  2.39 (6.71)  2.46 (6.32)  2.43 (6.49) 
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Total randomised to support arm, n  401  539     
Accepted referral, n (%)  278 (69.3)  444 (82.4)  0.48 (0.35, 0.66)  <0.001 
Attended weight loss programme (overall), n (%)  122 (30.4)  257 (47.6)  0.48 (0.36, 0.63)  <0.001 
      Mean difference (95% CI)   
Number of sessions attended, mean (sd)  9.66 (3.24)  9.08 (3.47)  0.62 (‐0.25, 1.48)  0.16 
12‐month weight loss BOCF in support arm (N= 
940), mean (sd) 




6.05 (8.56)  4.37 (7.57)  0.80 (‐1.01, 2.62)  0.39 
 
